Canada - English - Health Canada

genmed a division of pfizer canada ulc - tranexamic acid - solution - 100mg - tranexamic acid 100mg - hemostatics

Canada - English - Health Canada

marcan pharmaceuticals inc - tranexamic acid - tablet - 500mg - tranexamic acid 500mg - hemostatics

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - active: tranexamic acid 100 mg/ml excipient: nitrogen water for injection - haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. localfibrinolysis may occur in the following conditions: · prostatectomy and bladder surgery · menorrhagia · epistaxis · conisation of the cervix · management of dental extraction in patients with coagulopathies · ulcerative colitis · haematuria (tranexamic acid therapy is not indicated in haematuria caused by diseases of the renal parenchyma (also see precautions). · gastrointestinal haemorrhage

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - active: tranexamic acid 100 mg/ml excipient: nitrogen water for injection - haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. localfibrinolysis may occur in the following conditions: · prostatectomy and bladder surgery · menorrhagia · epistaxis · conisation of the cervix · management of dental extraction in patients with coagulopathies · ulcerative colitis · haematuria (tranexamic acid therapy is not indicated in haematuria caused by diseases of the renal parenchyma (also see precautions). · gastrointestinal haemorrhage

New Zealand - English - Medsafe (Medicines Safety Authority)

luminarie group limited - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - active: tranexamic acid 100 mg/ml excipient: water for injection - adults: for the reduction of peri - and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. paediatrics: for the reduction of peri - and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tranexamic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; purified talc; colloidal anhydrous silica; povidone; vanillin; macrogol 8000; magnesium stearate; titanium dioxide; basic butylated methacrylate copolymer - oral administration hereditary angioneurotic oedema. short term use in the treatment of hyphaema and in patients with established coagulopathies who are undergoing minor surgery. menorrhagia.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tranexamic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: macrogol 8000; vanillin; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; titanium dioxide; purified talc; povidone; basic butylated methacrylate copolymer - oral administration hereditary angioneurotic oedema. short term use in the treatment of hyphaema and in patients with established coagulopathies who are undergoing minor surgery. menorrhagia.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tranexamic acid, quantity: 500 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; purified talc; croscarmellose sodium; vanillin; povidone; macrogol 8000; titanium dioxide; magnesium stearate; basic butylated methacrylate copolymer - oral administration hereditary angioneurotic oedema. short term use in the treatment of hyphaema and in patients with established coagulopathies who are undergoing minor surgery. menorrhagia.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tranexamic acid -